Lamivudine Teva Pharma B.V. European Union - English - EMA (European Medicines Agency)

lamivudine teva pharma b.v.

teva b.v.  - lamivudine - hiv infections - antivirals for systemic use - lamivudine teva pharma b.v. is indicated as part of antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (hiv)-infected adults and children.

Lamivudine/Zidovudine Teva European Union - English - EMA (European Medicines Agency)

lamivudine/zidovudine teva

teva pharma b.v.  - lamivudine, zidovudine - hiv infections - antivirals for systemic use - lamivudine/zidovudine teva is indicated in antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (hiv) infection.

Zeffix European Union - English - EMA (European Medicines Agency)

zeffix

glaxosmithkline (ireland) limited - lamivudine - hepatitis b, chronic - antivirals for systemic use - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate;, decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

ARTIGE methylphenidate hydrochloride 10mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

artige methylphenidate hydrochloride 10mg tablet blister pack

novartis pharmaceuticals australia pty ltd - methylphenidate hydrochloride, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; calcium phosphate; purified talc; lactose monohydrate; wheat starch; gelatin - treatment of attention-deficit hyperactivity disorder (adhd). treatment of narcolepsy.

Abacavir/Lamivudine 600 mg/300 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

abacavir/lamivudine 600 mg/300 mg film-coated tablets

accord healthcare limited - abacavir; lamivudine - film-coated tablet - 600/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir